Vincent Medical Holdings Dirección
Dirección controles de criterios 3/4
El CEO de Vincent Medical Holdings' es Raymond Choi , nombrado en Jan 2023, tiene una permanencia de 1.25 años. compensación anual total es HK$1.52M, compuesta por 80.8% salario y 19.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.48% de las acciones de la empresa, por valor de HK$3.69M. La antigüedad media del equipo directivo y de la junta directiva es de 2 años y 7.8 años, respectivamente.
Información clave
Raymond Choi
Chief Executive Officer (CEO)
HK$1.5m
Compensación total
| Porcentaje del salario del CEO | 80.8% |
| Permanencia del CEO | 1.3yrs |
| Participación del CEO | 1.5% |
| Permanencia media de la dirección | 2.1yrs |
| Promedio de permanencia en la Junta Directiva | 7.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)
Dec 21
Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital
Aug 29Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
May 30Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
Dec 15One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat
Aug 07Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall
Aug 06Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
May 25Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
Apr 27Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year
Apr 07Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive
Mar 08Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term
Jul 27Is Vincent Medical Holdings (HKG:1612) A Risky Investment?
Jun 06One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%
Mar 28Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 25Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital
Mar 23Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?
Mar 04I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease
Feb 17Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?
Feb 04
What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition
Jan 22Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%
Jan 08Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 26What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation
Dec 14Did Vincent Medical Holdings Limited (HKG:1612) Insiders Buy Up More Shares?
Dec 02Can Vincent Medical Holdings (HKG:1612) Keep Up These Impressive Returns?
Nov 20Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | HK$2m | HK$1m | HK$57m |
Compensación vs. Mercado: La compensación total ($USD193.52K) de Raymond está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD232.54K).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Raymond con los resultados de la empresa.
CEO
Raymond Choi (40 yo)
1.3yrs
Permanencia
HK$1,515,000
Compensación
Mr. Cheung Tai Choi, also known as Raymond, served as Deputy Chief Executive Officer of Vincent Medical Holdings Limited since January 1, 2022 until January 1, 2023 and serves as its Chief Executive Office...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 8.5yrs | HK$1.49m | 1.68% HK$ 4.3m | |
| CEO & Executive Director | 1.3yrs | HK$1.52m | 1.48% HK$ 3.8m | |
| VP of OEM Business & Executive Director | no data | HK$1.47m | 0.78% HK$ 2.0m | |
| Executive Director | no data | HK$1.42m | 0.93% HK$ 2.4m | |
| Chief Financial Officer | no data | sin datos | sin datos | |
| Associate Director of Operations | no data | sin datos | sin datos | |
| Head of Investor Relations | no data | sin datos | sin datos | |
| Vice President of Sales & Marketing | no data | sin datos | sin datos | |
| Head of Sales & Marketing of Greater China | 2.1yrs | sin datos | sin datos | |
| Company Secretary | 7yrs | sin datos | sin datos |
2.1yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 1612 se considera experimentado (2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 8.5yrs | HK$1.49m | 1.68% HK$ 4.3m | |
| CEO & Executive Director | 1.3yrs | HK$1.52m | 1.48% HK$ 3.8m | |
| VP of OEM Business & Executive Director | 8.2yrs | HK$1.47m | 0.78% HK$ 2.0m | |
| Executive Director | 8.2yrs | HK$1.42m | 0.93% HK$ 2.4m | |
| Independent Non-Executive Director | 7.9yrs | HK$240.00k | sin datos | |
| Independent Non-Executive Director | 7.9yrs | HK$276.00k | sin datos | |
| Independent Non-Executive Director | 7.3yrs | HK$264.00k | sin datos | |
| Non Executive Director | less than a year | HK$99.00k | sin datos |
7.9yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de 1612 se considera experimentada (7.8 años de antigüedad promedio).